$STLN 4/A SEC Filings

Filed On	Filing
06 Jan 2026	Form 4/A: Carter Robert Ross, Chief Financial Officer Disposed of 244 shares (Other Transaction) ($895)
28 Apr 2025	Form 4/A: Hively Brad, Director Bought 45,280 shares ($47.2K) · Acquired 22,640 Common Warrant (Open Market Purchase) ($2.83K)
30 Dec 2022	Form 4/A: Barasch Richard A, Director Received 65,174 shares as a grant or award
22 Nov 2022	Form 4/A: Virnich Daniel, President Sold 3,767 shares ($7.64K)
22 Nov 2022	Form 4/A: Simoneit Diona, Chief Accounting Officer Sold 190 shares ($385)
22 Nov 2022	Form 4/A: Podnos Yale, Chief Medical Officer Sold 199 shares ($404)
22 Nov 2022	Form 4/A: Miller Matthew P, Chief Operating Officer Sold 577 shares ($1.17K)
22 Nov 2022	Form 4/A: Hively Brad, Chief Executive Officer Sold 9,718 shares ($19.7K)
29 Mar 2022	Form 4/A: Miller Matthew P, Chief Operating Officer Granted 142,261 Stock Option (right to buy)
29 Mar 2022	Form 4/A: Podnos Yale, Chief Medical Officer Granted 75,551 Stock Option (right to buy)
29 Mar 2022	Form 4/A: Virnich Daniel, President Granted 213,259 Stock Option (right to buy)
29 Mar 2022	Form 4/A: Dalgleish Scott, Chief Financial Officer Granted 162,891 Stock Option (right to buy)
29 Mar 2022	Form 4/A: Hively Brad, Director Granted 550,563 Stock Option (right to buy)
22 Nov 2021	Form 4/A: Sarin Ravi Yang, Director Received 4,109,771 shares as a grant or award · Granted 872,495 Earn Out Rights
18 Nov 2021	Form 4/A: Hively Brad, Director Received 353,450 shares as a grant or award
18 Nov 2021	Form 4/A: Kaushal Mohit, Director Received 30,000 shares by exercise or conversion
18 Nov 2021	Form 4/A: Barasch Richard A, Director Received 100,000 shares by exercise or conversion · Returned 14,887 shares to the issuer

Comments